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Abstract
Gout is a well-known inflammatory arthritis and affects four percent of the United States
population. It results from the deposition of uric acid crystals in joints, tendons, bursae, and
other surrounding tissues. Prevalence of gout has increased in the recent decade. Gout is
usually seen in conjunction with other chronic comorbid conditions like cardiac disease,
metabolic syndrome, and renal disease. The diagnosis of this inflammatory arthritis is
confirmed by visualization of monosodium urate (MSU) crystals in the synovial fluid. Though
synovial fluid aspiration is the standard of care, it is often deferred because of inaccessibility of
small joints, patient assessment during intercritical period, or procedural inexperience in a
primary care office. Dual energy computed tomography (DECT) is a relatively new imaging
modality which shows great promise in the diagnosis of gout. It is a good noninvasive
alternative to synovial fluid aspiration. DECT is increasingly useful in diagnosing cases of gout
where synovial fluid fails to demonstrate monosodium urate crystals. In this article, we will
review the mechanism, types, advantages, and disadvantages of DECT.
Categories: Internal Medicine, Radiology, Rheumatology
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Introduction And Background
Gout is a crystal-induced inflammatory arthritis, which is one of the oldest and commonest
rheumatic diseases [1-2]. The prevalence of gout is steadily increasing and it currently affects
approximately 8.3 million individuals (3.9%) in the United States [2]. Deposition of
monosodium urate (MSU) crystals in the joint spaces and tissues is the hallmark of gout. Gout
is characterized clinically by acute onset of inflammatory mono-/ oligoarthritis and is often
difficult to distinguish from other inflammatory arthritides without confirmation by synovial
fluid analysis. Synovial fluid aspiration and visualization of MSU crystals has long been
recognized as the gold standard for gout diagnosis. There are limited options to confirm the
suspicion of gout when patients present during the intercritical phase. Asymptomatic
hyperuricemia is common and only a few percent of those patients progress to develop gout.
Recent advances in technology have led us to the use of energy rays to specifically detect MSU
crystals in tendons, joints, bursae, and soft tissues. Dual energy computed tomography (DECT)
is an upcoming imaging modality in rheumatology and shows great promise in diagnosing
challenging cases of gout [3-5]. In this review, we will discuss the mechanism, types,
advantages, and disadvantages of DECT.
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DECT is a modified computed tomography (CT) scan that utilizes two X-rays instead of one, as
seen in a standard CT scan. It uses a regular X-ray and a lower energy X-ray at 140 kV and 80 kV
to produce images of different types of tissues [6-7]. The difference in photoelectric absorption
between calcium and urate allows measurable attenuation differences between urate and bone
[8]. An image is thus created by distinctively separating and color coding calcium from
monosodium urate. A DECT scan is considered positive by the presence of color-coded
monosodium urate at joints and periarticular spaces [9]. In Figure 1, the MSU crystals are
demonstrated in green while the calcium is demonstrated in purple. The color enhanced
positivity reflects dense packaging of MSU crystals by extracellular neutrophil traps (NETs) [10].
DECT protocol is usually limited to the affected joint area. Comprehensive scanning for
research purposes can include bilateral hands and wrists, elbows, knees, feet, and ankles [11-
12]. This helps detect MSU deposits in multiple articular and periarticular sites by a single scan
[13]. A DECT scan of joints like the spine and shoulders are rarely clinically indicated and
therefore are not studied extensively.
FIGURE 1: 3D DECT reconstruction images
Image showing a patient with tophaceous gout previous to (a) and 16 months after treatment
with febuxostat (b). Image 1b shows complete resolution of the tophi (areas of green pixels
around the nails represent typical artifacts); Purple: calcium; Green: MSU deposits; A: anterior
(Reproduced with permission from journal-Gout and Hyperuricemia).
DECT is an innovative imaging technique with a reported sensitivity of 84%–90% and
specificity of 83%–93% [14-15]. It has recently made its way to the 2015 American College of
Rheumatology (ACR)/European League against Rheumatism (EULAR) diagnostic criteria for
gout. The target population fulfilling the diagnostic criteria are those patients demonstrating at
least one episode of swelling, pain or tenderness in a bursa or joint space [9]. The detection of
MSU crystals in the symptomatic joints on DECT scan is sufficient for the diagnosis of gout [9].
This is based on the Study for Updated Gout Classification Criteria (SUGAR) and includes
clinical, laboratory, and imaging characteristics of gout. The new ACR/EULAR classification
criteria showed a sensitivity of 92% and specificity of 89% [9, 16]. A study by Petsch, et al.
observed that a considerable number of seronegative rheumatoid arthritis (RA) patients with
hyperuricemia had periarticular MSU crystal deposits in DECT scan. This finding suggested that
some patients fulfilling ACR/EULAR criteria for RA may be suffering from polyarticular gout
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rather than RA [13].
DECT has several advantages, it helps avoid an invasive procedure like synovial fluid aspiration,
which carries the risk of bleeding, infection, and has low yield in small joints [17]. As
demonstrated in Figure 2, gout in small joints like the metatarsophalangeal joints is easily
revealed by DECT. Though synovial fluid aspiration is considered the gold standard, it is often
deferred in the primary care or emergency care setting where a majority of patients are
managed [18]. An accurate diagnosis will reduce inappropriate treatment and institute early
interventions to prevent long term complications like joint destruction, and renal and cardiac
manifestations.
FIGURE 2: DECT multiplanar reformation (MPR)
Images revealing multiple MSU tophi formations (in green) in the first left metatarsophalangeal
joint (2a), in front of the right tibia (2b) and around the right medial cuneiform (2c). Smaller
lesions were also seen in the right 1st and 4th metatarsophalangeal joints (2a). (Reproduced
with permission from SOMATOM Sessions and X-LEME Diagnóstico por Imagem, Curitiba,
Brazil).
Another useful characteristic of DECT is the quantification of tophi burden in a joint, which is a
terminal manifestation of this disease. This will help monitor the efficacy of urate lowering
therapy in addition to diagnosis. As seen in Figure 1, 3D demonstration of DECT illustrates
complete resolution of tophi after adequate treatment with febuxostat [4, 15]. This allows
quantitative monitoring of tophi and appropriate response to treatment. DECT is also
particularly useful to diagnose gout in patients where synovial fluid does not demonstrate any
MSU crystals [14]. In a study at Mayo clinic, 30% of patients who had gout diagnosed by DECT,
did not have MSU crystals in synovial fluid analysis [14]. This is likely due to MSU crystals
clustering around tendons and ligaments instead of the articular space.
Other imaging techniques available for gout are radiography, ultrasonography (USG),
conventional CT, and magnetic resonance imaging (MRI). Erosive changes in radiography
manifests late in disease, and conventional CT cannot distinguish MSU deposits. On the other
hand, USG is an inexpensive and well-accepted diagnostic tool. The double contour sign in USG
is characteristic, but there is lack of standardized methodology and sometimes exhaustive
scanning is required [19]. These imaging tools therefore lack specificities for implementation
on a larger scale [3, 12, 20].
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At present, there are five different types of DECT scanners available: Dual source DECT, twin-
beam single-source CT with gold filter, rapid kilovoltage-switching source with gemstone
scintillator detector, dual-layer multidetector DECT, and dual-scan single source [8].
The amount of radiation involved in DECT ranges between 2 to 3 mSv, though it is dependent
on the technology used [12, 21]. This low dose of radiation offers a satisfactory replacement of
standard CT scans. Strategies that lead to dose reduction include tube current modulation,
iterative reconstruction techniques, and new detector application-specific integrated circuits
(ASICs) which integrate photodiode and analog digital converters [21]. DECT also limits
radiation to extremities which are not typically radiosensitive regions. This may reduce
radiation-related cancer risk, though there is paucity of literature is this area.
Though DECT shows great potential, it is not without limitations. It is user dependent and
imaging results should be interpreted with caution by a professional who is well-trained to
recognize artifacts. Locations notorious for artefacts were nose, skin, calluses, nail bed, flexor
and peroneal tendons, and around arthroplasties [5, 21]. The most common of these is of the
nail and nail bed, mainly in the feet, observed in 88% of patients. Figure 1b exhibits the
commonly seen nail artifact, which is seen in green pixels [11]. Other artifacts encountered
were submillimeter ones caused by noise and beam hardening, seen as an isolated linear
pattern. Though common, artifacts are well recognized and easy to rectify for DECT-trained
radiologists. False positives can be reduced with measures like physical patient adjustments,
increasing gantry speeds for decreasing motion artifacts or adjustment of individual settings
during interpretation [11]. 
False positive results are also observed in patients with high grade osteoarthritis. This may be
theorized as either a representation of joint damage causing matrix exposure and MSU
crystallization or an imaging artifact [14]. Though DECT scan has good accuracy in diagnosing
gout in patients with established disease, it appears to have low sensitivity in the first episode
of gout in patients with no prior history. This is detailed in a study by Bongartz, et al., where
20% of patients with no prior history of gout failed to demonstrate MSU crystals on DECT
imaging. This was attributed to the increasingly small size of deposits in early disease [14]. In a
more recent review presented by the US department of Health and Human Services, sensitivity
of DECT in patients with initial gout episode was 85% or more, though strength of evidence was
low.
Conclusions
The increase in prevalence of gout in the past two decades may be attributed to lifestyle causing
obesity, hyperlipidemia, hypertension, diabetes, and renal disease. This causes a burden on the
ambulatory services and was estimated to be 2 million visits for acute attacks annually. Various
inflammatory arthritides such as pseudogout, rheumatoid arthritis, psoriatic arthritis, septic
arthritis can mimic gout. DECT offers great potential as a screening and diagnostic tool to
detect MSU crystals accurately and should be implemented on a larger scale. DECT is a
promising tool to diagnose gout reliably and also measure the total uric acid burden in the
body.
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